Annamari Ranki

Annamari Ranki

Auto-generated profile, based on publicly available information

Annamari Ranki

Department of Skin and Allergic Diseases, University of Helsinki, Helsinki University Central Hospital, P.O. Box 160, 00029 HUS Helsinki, Finland

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ASAlexander Salava
Alexander Salava
PDPaulina Deptula
Paulina Deptula
ALAnnina Lyyski
Annina Lyyski
PLPia Laine
Pia Laine
LPLars Paulin
Lars Paulin
ALAntti Lauerma
Antti Lauerma

1 January 1992 in AIDS
Verified
Journal Article
Closed access
VOVladimir Ovod
Vladimir Ovod
ALAnssi Lagerstedt
Anssi Lagerstedt
ARAnnamari Ranki
Annamari Ranki
FGFrank Otto Gombert
Frank Otto Gombert
RSRenate Spohnt
Renate Spohnt
KKKai J.E. Krohn
Kai J.E. Krohn
To study the immunological and immunohistochemical nature of HIV-1 Nef.Monoclonal anti-Nef antibodies were generated and used to identify antigenic epitopes in Nef, to study immunological cross-reactivity between Nef from different isolates and to reveal the subcellular localization of Nef.Monoclonal antibodies against recombinant HIV-1 Nef protein (BRU isolate) were generated in BALB/c mice. The epitope mapping was carried out with the use of overlapping 15-20mer lipopeptides linked to a lipid group at the amino-terminus. Immunoperoxidase method was used for histochemical studies.Ten stable antibody-producing clones, mainly of the immunoglobulin (Ig) G1 subtype, with strong Western blot and enzyme-linked immunosorbent assay reactivity toward the recombinant Nef protein, were obtained. The epitopes recognized were located on amino-acid sequences 21-41, 31-50, 51-71, 61-80, 151-170, 161-180, and 171-190. All 10 monoclonal antibodies also reacted with the native Nef of HIV-1BRU, and eight reacted with native HIV-1IIIB. Most antibodies also reacted with Nef from more divergent HIV-1 strains. In Western blotting, two forms of Nef (24 and 27 kDa) were observed with most isolates studied. Immunohistochemical staining of HIV-1-infected H9 or MT-4 lymphoid cells demonstrated that Nef was expressed mainly in the Golgi complex and at the nuclear membrane, but occasionally also in the nucleus. The nuclear localization of Nef was especially frequent in the HIV-1-infected MT-4 cells.Our findings suggest that Nef is expressed in two isomorphic forms, and that it may also act as a nuclear protein and thus have a direct regulatory function at the RNA/DNA level.

1 December 1992 in AIDS
Verified
Journal Article
Closed access
BKBirgit Kohleisen
Birgit Kohleisen
MNMarkus Neumann
Markus Neumann
RHReiner Herrmann
Reiner Herrmann
RBRuth Brack-Werner
Ruth Brack-Werner
KKKai J.E. Krohn
Kai J.E. Krohn
VEVolker Erfle
Volker Erfle
The characterization and localization of HIV-1 Nef highly expressed in permanently infected astrocytes (TH4–7-5) as a model for latent infection of human brain cells. Immunochemical methods are an appropriate tool to investigate expression and localization of cellular proteins. Nef expression was analysed by Western blot and immunoperoxidase staining using a panel of monoclonal and polyclonal antibodies. Cellular localization studies were performed by indirect immunofluorescence and subcellular fractionation of TH4–7-5 cells. Myristoylation of Nef was investigated by immunoprecipitation of [3H]myristic acid-labelled cell extract. TH4–7-5 nef gene was cloned and amplified by polymerase chain reaction and the nef nucleotide sequence analysed. Reactivities of various Nef-specific antibodies with Nef antigen in TH4–7-5 cells were demonstrated by Western blot analysis. Immunofluorescence revealed cytoplasmic perinuclear staining of Nef with most antibodies. However, one monoclonal antibody against amino acids 168–175 of Nef showed intense homogeneous nuclear staining in TH4–7-5 cells. Reactivity of this Nef antibody was blocked with recombinant Nef derived from TH4–7-5 cells. After subcellular fractionation, Nef was detected in nuclear, membrane and cytosolic fractions of TH4–7-5 cells. No myristoylated Nef antigen was detectable, perhaps because of a serine residue at position 2 of the TH4–7-5 nef gene instead of the glycine residue required for myristoylation. Chronically HIV-1-infected astrocytoma cells with restricted virus production express different antigenic forms of Nef, which can be distinguished by their subcellular localization. Variant subcellular targeting of Nef suggests the existence of multiple activities of Nef within HIV-infected cells.

10 February 2017 in OncoImmunology
Verified
Journal Article
Open access
PMPilvi Maliniemi
Pilvi Maliniemi
Kirsi LaukkanenKirsi Laukkanen
Kirsi Laukkanen
LVLiisa Väkevä
Liisa Väkevä
Katja DettmerKatja Dettmer
Katja Dettmer
TLTuomas Lipsanen
Tuomas Lipsanen
ARAnnamari Ranki
Annamari Ranki
Indoleamine 2,3-deoxygenase 1 (IDO1) induces immune tolerance in the tumor microenvironment (TME) and is recognized as a potential therapeutic target. We studied the expression of both IDO1 and the related tryptophan 2,3-dioxygenase (TDO) in several different subtypes of cutaneous T-cell lymphoma (CTCL), and evaluated the kynurenine (KYN) pathway in the local TME and in patient sera. Specimens from the total of 90 CTCL patients, including mycosis fungoides (MF, n = 37), lymphomatoid papulosis (LyP, n = 36), primary cutaneous anaplastic large cell lymphoma (pcALCL, n = 4), subcutaneous panniculitis-like T-cell lymphoma (SPTCL n = 13), and 10 patients with inflammatory lichen ruber planus (LRP), were analyzed by immunohistochemistry (IHC), immunofluorescence (IF), quantitative PCR, and/or liquid chromatography–tandem mass spectrometry (LC–MS/MS). Three CTCL cell lines also were studied. Expression of both IDO1 and TDO was upregulated in CTCL. In MF specimens and in the MF cell line MyLa2000, IDO1 expression exceeded that of TDO, whereas the opposite was true for LyP, ALCL, and corresponding Mac1/2A cell lines. The spectrum of IDO1-expressing cell types differed among CTCL subtypes and was reflected in the clinical behavior. In MF, SPTCL, and LyP, IDO1 was expressed by malignant cells and by CD33+ myeloid-derived suppressor cells, whereas in SPTCL CD163+ tumor-associated macrophages also expressed IDO1. Significantly elevated serum KYN/Trp ratios were found in patients with advanced stages of MF. Epacadostat, an IDO1 inhibitor, induced a clear decrease in KYN concentration in cell culture. These results show the importance of IDO1/TDO-induced immunosuppression in CTCL and emphasize its role as a new therapeutic target.

15 December 2011 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
ECE Carlsson
E Carlsson
ARA Ranki
A Ranki
LSL Sipilä
L Sipilä
LKL Karenko
L Karenko
WAWael Abdel-Rahman
Wael Abdel-Rahman
KKK Krohn
K Krohn
The recently described navigator proteins have a multifaceted role in cytoskeletal dynamics. We report here on the relevance of one of them, navigator 3 (NAV3), in colorectal cancer (CRC). We analysed changes in chromosome 12 and NAV3 copy number in CRC/adenoma samples of 59 patients and in 6 CRC cell lines, using fluorescence in situ hybridisation, loss of heterozygosity, and array-CGH. NAV3 target genes were identified by siRNA depletion, expression arrays, and immunohistochemistry. NAV3 deletion and chromosome 12 polysomy were detected in 30 and 70% of microsatellite stability (MSS) carcinomas, in 23 and 30% of adenomas and in four of six CRC cell lines. NAV3 amplification was found in 25% of MSS samples. NAV3 alterations correlated with lymph node metastasis. In normal colon cells, NAV3 silencing induced upregulation of interleukin 23 receptor (IL23R) and gonadotropin releasing hormone receptor. In MSS and microsatellite instability tumours, IL23R immunoreactivity correlated with Dukes’ staging and lymph node metastases, whereas nuclear beta-catenin correlated with lymph node metastases only. NAV3 copy number changes are frequent in CRC and in adenomas, and upregulation of IL23R, following NAV3 silencing, strongly correlates with Dukes’ staging and lymph node metastases. This suggests that NAV3 has a role in linking tissue inflammation to cancer development in the colon.

1 December 2001 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
HNH. Nevala
H. Nevala
LKL. Karenko
L. Karenko
LVL. Vakeva
L. Vakeva
ARA. Ranki
A. Ranki